Abstract
Endocannabinoids have been shown to activate reward-related feeding and to promote astrocytic differentiation. We investigated whether high-fat diet (HFD) intake produced a preference for HFD via an endocannabinoid-dependent mechanism. In the conditioned place preference test, the 2-week HFD-intake group showed preference for HFD and had increased expression of a marker for reactive astrocytes, glial fibrillary acid protein (GFAP), in the hypothalamus. The cannabinoid CB1-receptor antagonist O-2050 reduced the preference for HFD and expression of GFAP in the hypothalamus. These results suggested that HFD intake led to the development of a preference for HFD via astrocytic CB1 receptors in the hypothalamus. © 2010 The Japanese Pharmacological Society.
Author supplied keywords
Cite
CITATION STYLE
Higuchi, S., Irie, K., Mishima, S., Araki, M., Ohji, M., Shirakawa, A., … Fujiwara, M. (2010). The cannabinoid 1-receptor silent antagonist O-2050 attenuates preference for high-fat diet and activated astrocytes in mice. Journal of Pharmacological Sciences, 112(3), 369–372. https://doi.org/10.1254/jphs.09326SC
Register to see more suggestions
Mendeley helps you to discover research relevant for your work.